Skip to main content
. 2022 Feb 12;50(5):2566–2586. doi: 10.1093/nar/gkac081

Figure 3.

Figure 3.

Regulation of MEF2-class IIa HDACs axis by PAOA-derivatives. (A) GST pull-down assay, using recombinant MEF2D (1–190) or GST as control. Purified GST or GST-MEF2D recombinant proteins (2 μg) were incubated with cellular lysates obtained from NIH3T3 cells overexpressing HDAC4 mutated in 14–3–3 binding sites. Two different concentrations [14 and 42 μM] were used. Immunoblots were performed to visualize HDAC4 or recombinant GST. (B) SK-UT-1 cells were treated for the indicated times with NKL54 [5 μM] or SAHA [2.5 μM]. Cellular lysates were generated and immunoblot performed using the indicated antibodies. Actin and Histone 3 (H3) were used as loading control. (C) Lysates from SK-UT-1 cells treated for 12 h with DMSO or with SAHA [2.5 μM] or NKL54 [5μM] MEF2D-HDAC4 complexes were immunoprecipitated with antibodies against HDAC4 or USP33, as a control. Immunoblotting using an anti-MEF2D antibody was next used for the detection of the MEF2-HDAC4 complexes. Asterisks point to IGs.